ATNM
Actinium Pharmaceuticals Inc
1.20$
+0.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 97.9% | 99.6% | 99.4% | 97.3% | 96.2% | 86.4% | 97.8% | 99.2% | 97.2% | 96.1% | 96.9% | 95.4% | |
| 88.6% | 96.4% | 91.1% | 94.9% | 91.8% | 79.3% | 95.8% | 96.8% | 95.4% | 94.1% | 94.8% | 92.7% | |
| 88.8% | 96.4% | 91.1% | 94.9% | 91.8% | 79.3% | 95.8% | 96.8% | 95.4% | 94.1% | 94.8% | 92.7% | |
| 1.7% | 0.4% | 0.4% | 0.3% | 0.8% | 9.8% | 1.6% | 0.8% | 2.6% | – | – | – | |
| 125.4% | 17.4% | 20.1% | 25.4% | 40.8% | 51.6% | 7.6% | 8.5% | 41.8% | 55.3% | 57.4% | 84.9% | |
| 125.4% | 17.4% | 20.1% | 25.4% | 40.7% | 45.8% | 7.2% | 8.5% | 9.3% | 10.4% | 10.6% | 15.4% | |
| 3.7% | 1.0% | 1.3% | 0.1% | 1.7% | 6.4% | 0.6% | 0.4% | 0.4% | 0.7% | 0.8% | 1.4% | |
| 30.2% | 5.5% | 18.6% | 25.4% | 39.0% | 39.4% | 6.5% | 6.9% | 8.9% | 9.8% | 9.8% | – | |
| -25.4% | 82.6% | 79.9% | 74.6% | 59.2% | 48.4% | 92.4% | 91.5% | 58.2% | 44.7% | 42.6% | 15.1% | |
| -1,205.0% | -422.1% | -606.1% | -889.7% | -1,255.0% | -1,788.8% | -347.9% | -318.1% | -252.9% | -414.5% | -488.7% | -791.3% | |
| 12.1% | 4.8% | 7.2% | 12.1% | 23.7% | 42.6% | 18.3% | 25.6% | 21.1% | 32.7% | 39.1% | 60.3% |
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.